These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism. Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715 [TBL] [Abstract][Full Text] [Related]
28. Clinical features and prognosis of patients with benign thyroid disease accompanied by an incidental papillary carcinoma. Wang SF; Zhao WH; Wang WB; Teng XD; Teng LS; Ma ZM Asian Pac J Cancer Prev; 2013; 14(2):707-11. PubMed ID: 23621223 [TBL] [Abstract][Full Text] [Related]
29. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma. Li WF; Wang G; Zhao ZB; Liu CA Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110 [TBL] [Abstract][Full Text] [Related]
30. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma. Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332 [TBL] [Abstract][Full Text] [Related]
31. Contribution of immunocytochemical stainings for galectin-3, CD44, and HBME1 to fine-needle aspiration cytology diagnosis of papillary thyroid carcinoma. Das DK; Al-Waheeb SK; George SS; Haji BI; Mallik MK Diagn Cytopathol; 2014 Jun; 42(6):498-505. PubMed ID: 24273003 [TBL] [Abstract][Full Text] [Related]
32. Hashimoto's thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients. Ma H; Li L; Li K; Wang T; Zhang Y; Zhang C; Xu Y; Wu X; Yu J; Wang H; Xiang B; Zhang R; Wang W Neoplasma; 2018 Mar; 65(3):436-440. PubMed ID: 29788738 [TBL] [Abstract][Full Text] [Related]
33. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma. Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746 [TBL] [Abstract][Full Text] [Related]
34. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis. Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342 [TBL] [Abstract][Full Text] [Related]
35. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease. Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233 [TBL] [Abstract][Full Text] [Related]
36. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma. Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220 [TBL] [Abstract][Full Text] [Related]
37. Ultrasonographic Features, Nodule Size, Capsular Invasion, and Lymph Node Metastasis of Solitary Papillary Carcinoma of Thyroid Isthmus. Luo H; Yan F; Lan L; Ma B; Zhao H; He Y; Peng Y Front Oncol; 2020; 10():558363. PubMed ID: 33117691 [No Abstract] [Full Text] [Related]
38. Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiter. Dong W; Li J; Huang Y; Zhang H; Shan Z; Teng W Med Sci Monit; 2012 Sep; 18(9):BR351-5. PubMed ID: 22936184 [TBL] [Abstract][Full Text] [Related]
39. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma. Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940 [TBL] [Abstract][Full Text] [Related]
40. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer. Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]